It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact

That’s gratitude, eh? It’s not even a fortnight since the government agreed to raise the prices the NHS pays for new medicines and here comes the boss of GSK, the UK’s second largest pharma firm, to extol the virtues of doing business in the US.

The US is “still the leading market in the world in terms of the launches of new drugs and vaccines,” said the chief executive, Emma Walmsley , in a BBC interview , explaining why GSK invests about three times as much over there as it does at home. Alongside China, the US is also “the best market in the world to do business development”.

It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact

That’s gratitude, eh? It’s not even a fortnight since the government agreed to raise the prices the NHS pays for new medicines and here comes the boss of GSK, the UK’s second largest pharma firm, to extol the virtues of doing business in the US.

The US is “still the leading market in the world in terms of the launches of new drugs and vaccines,” said the chief executive, Emma Walmsley , in a BBC interview , explaining why GSK invests about three times as much over there as it does at home. Alongside China, the US is also “the best market in the world to do business development”.

It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact

That’s gratitude, eh? It’s not even a fortnight since the government agreed to raise the prices the NHS pays for new medicines and here comes the boss of GSK, the UK’s second largest pharma firm, to extol the virtues of doing business in the US.

The US is “still the leading market in the world in terms of the launches of new drugs and vaccines,” said the chief executive, Emma Walmsley , in a BBC interview , explaining why GSK invests about three times as much over there as it does at home. Alongside China, the US is also “the best market in the world to do business development”.

Sandie Peggie won harassment claim against NHS Fife but tribunal dismissed claims of discrimination and victimisation

Sandie Peggie, the Fife nurse who was suspended after she complained about sharing a female changing room with a transgender doctor, will appeal against a “hugely problematic” employment tribunal ruling, her solicitor has confirmed.

On Monday, the ruling of a lengthy employment tribunal found that Peggie, who has worked as a nurse for more than 30 years, had been harassed by NHS Fife when she was expected to share the changing room with Dr Beth Upton.

Sandie Peggie won harassment claim against NHS Fife but tribunal dismissed claims of discrimination and victimisation

Sandie Peggie, the Fife nurse who was suspended after she complained about sharing a female changing room with a transgender doctor, will appeal against a “hugely problematic” employment tribunal ruling, her solicitor has confirmed.

On Monday, the ruling of a lengthy employment tribunal found that Peggie, who has worked as a nurse for more than 30 years, had been harassed by NHS Fife when she was expected to share the changing room with Dr Beth Upton.

Sandie Peggie won harassment claim against NHS Fife but tribunal dismissed claims of discrimination and victimisation

Sandie Peggie, the Fife nurse who was suspended after she complained about sharing a female changing room with a transgender doctor, will appeal against a “hugely problematic” employment tribunal ruling, her solicitor has confirmed.

On Monday, the ruling of a lengthy employment tribunal found that Peggie, who has worked as a nurse for more than 30 years, had been harassed by NHS Fife when she was expected to share the changing room with Dr Beth Upton.

London site’s theatre, music venue and galleries to close in June 2028, in first stage of upgrades before 50th anniversary

The Barbican will close its doors for 12 months from June 2028 as it undergoes a multimillion-pound renovation that its leaders say will secure its future.

The arts organisation’s Beech Street cinemas will remain open but its theatre, music venue, conservatory and visual arts galleries are set to shutter as the overhaul of the 43-year-old building begins in the lead-up to its 50th anniversary in 2032.

London site’s theatre, music venue and galleries to close in June 2028, in first stage of upgrades before 50th anniversary

The Barbican will close its doors for 12 months from June 2028 as it undergoes a multimillion-pound renovation that its leaders say will secure its future.

The arts organisation’s Beech Street cinemas will remain open but its theatre, music venue, conservatory and visual arts galleries are set to shutter as the overhaul of the 43-year-old building begins in the lead-up to its 50th anniversary in 2032.

London site’s theatre, music venue and galleries to close in June 2028, in first stage of upgrades before 50th anniversary

The Barbican will close its doors for 12 months from June 2028 as it undergoes a multimillion-pound renovation that its leaders say will secure its future.

The arts organisation’s Beech Street cinemas will remain open but its theatre, music venue, conservatory and visual arts galleries are set to shutter as the overhaul of the 43-year-old building begins in the lead-up to its 50th anniversary in 2032.